Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI

Magnetic Resonance in Medicine

Volumn 72, Issue 6, 2014, Pages 1696-1701

  Ahrens, Eric T ^a   Helfer, Brooke M ^b   O'Hanlon, Charles F ^b   Schirda, Claudiu ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Celsense Inc   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

19F; Cancer; Cell tracking; Dendritic cells; Fluorine 19; Immunotherapy; MRI; Perfluorcarbon

Indexed keywords

CYTOLOGY; DISEASES; FLUORINE; MAGNETIC RESONANCE IMAGING; TRACERS; MAGNETIC RESONANCE;

CANCER; CELL TRACKING; DENDRITIC CELLS; FLUORINE-19; IMMUNOTHERAPY; PERFLUORCARBON; ^19F;

CELLS;

CD86 ANTIGEN; DENDRITIC CELL VACCINE; FLUORINE; FLUOROCARBON; CONTRAST MEDIUM;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CANCER STAGING; CELL DENSITY; CELL MATURATION; CELL MOTILITY; CELL THERAPY; CELL VIABILITY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DENDRITIC CELL; DRUG SAFETY; EX VIVO STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; LIMIT OF DETECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; SIGNAL NOISE RATIO; T LYMPHOCYTE; TREATMENT DURATION; TREATMENT OUTCOME; AGED; CELL CULTURE; CELL TRACKING; CLINICAL TRIAL; COLORECTAL NEOPLASMS; COMPUTER ASSISTED SURGERY; FLUORINE MAGNETIC RESONANCE IMAGING; IMAGE ENHANCEMENT; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION; CANCER IMMUNIZATION; CELL COUNT; CELL LABELING; HUMAN CELL; IMAGING PHANTOM; NOTE; PHASE 1 CLINICAL TRIAL; SENSITIVITY ANALYSIS;

ADULT; AGED; CELL TRACKING; CELLS, CULTURED; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DENDRITIC CELLS; FEASIBILITY STUDIES; FEMALE; FLUORINE-19 MAGNETIC RESONANCE IMAGING; FLUOROCARBONS; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84984923544     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.25454     Document Type: Article

References (18)

1. Ahrens ET, Bulte JWM. Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol 2013;13:755-763.
2. Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med 2011;3:95ra73.
3. Bulte JWM. In vivo MRI cell tracking: clinical studies. Am J Roentgenol 2009;193:314-325.
4. Helfer BM, Balducci A, Nelson AD, Janjic JM, Gil RR, Kalinski P, De Vries IJM, Ahrens ET, Mailliard RB. Functional assessment of human dendritic cells labeled for in vivo F-19 magnetic resonance imaging cell tracking. Cytotherapy 2010;12:238-250.
5. Ahrens ET, Flores R, Xu HY, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 2005;23:983-987.
6. Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med 2007;58:725-734.
7. Srinivas M, Turner MS, Janjic JM, Morel PA, Laidlaw DH, Ahrens ET. In vivo cytometry of antigen-specific t cells using 19F MRI. Magn Reson Med 2009;62:747-753.
8. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
9. ClinicalTrials.gov. U. S. National Institites of Health website. www.clinicaltrials.gov. Trial #NCT01671592. Last update April 14, 2014.
10. Mailliard RB, Wankowicz-Kalinska A, Cai Q, Wesa A, Hilkens CM, Kapsenberg ML, Kirkwood JM, Storkus WJ, Kalinski P. alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res 2004;64:5934-5937.
11. Gudbjartsson H, Patz S. The Rician distribution of noisy MRI data. Magn Reson Med 1995;34:910-914.
12. Ahrens ET, Zhong J. In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection. NMR Biomed 2013;26:860-871.
13. Keupp J, Rahmer J, Grasslin I, Mazurkewitz PC, Schaeffter T, Lanza GM, Wickline SA, Caruthers SD. Simultaneous dual-nuclei imaging for motion corrected detection and quantification of 19F imaging agents. Magn Reson Med 2011;66:1116-1122.
14. De Vries IJ, Lesterhuis WJ, Barentsz JO, et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005;23:1407-1413.
15. Thu MS, Bryant LH, Coppola T, et al. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med 2012;18:463-467.
16. Cohn SM. Oxygen therapeutics in trauma and surgery. J Trauma 2003;54:S193-S198.
17. Zhong J, Mills PH, Hitchens TK, Ahrens ET. Accelerated fluorine-19 MRI cell tracking using compressed sensing. Magn Reson Med 2013;69:1683-1690.
18. Wald LL, Carvajal L, Moyher SE, Nelson SJ, Grant PE, Barkovich AJ, Vigneron DB. Phased-array detectors and an automated intensitycorrection algorithm for high-resolution mr-imaging of the human brain. Magn Reson Med 1995;34:433-439.